Hyalo Tirz Floaters!!
Lot HT 026
BUD 6/9/2026
This is a video of just one of my vials received yesterday. Others have them also!
Lot HT 026
BUD 6/9/2026
This is a video of just one of my vials received yesterday. Others have them also!
Back when I found out Apothecary was out and Hyalo was in, I panicked and clicked "delay" my September refill, because I wanted plenty of time to be able to read reviews of Hyalo before committing to the 3 month refill purchase.
That delayed refill is scheduled for the end of October. I went on the portal to try to switch it back to the original refill date of Sept. 28th, but it will not allow me to do that, there is no option to change anything about that shipment.
Can someone tell me what my options are to change that refill back to September?
This might be a strange question.
Has anyone ever noticed, with a change in pharmacy, that the new pharmacy Tirz hits its peak level in your system later than what was normal for you?
I have only ever used two pharmacies- both of which hit almost exactly the same with the same peak at 24/36 hours after injection.
Trying Apothecary for the first time, injection site stomach as usual, and I am only now, 3 full days after inj, feeling the peak with full-blown suppression and full-blown nausea, which is unusual for me after being on Tirz for 6 months now.
Can some compounds absorb slower or differently, and reach peak later than you are accustomed to, or might I just be getting a stomach bug or something?
This is my first time using a formulation with Phenol. I have only ever had Benzyl Alcohol prior. Curious if that can effect on how it absorbs in the body.
Has this ever been a thing for anyone else?
Looks like there is a big change coming for some Telehealths that use Apothecary. There is a shift from Apothecary's no additive formulation over to the new Hyalo due to Hyalo's 9 month BUD dates.
Will Gimmecare be making the transition over to Hyalo as well?
SHOW US THE SCIENCE
A Challenge to the Compounded GLP-1 Industry: Patients Deserve More Than 'Trust Us'
The future of compounded medicine shouldn't be built on reassurance. It should be built on evidence.
Introduction
Compounded GLP-1 medications have changed countless lives, including mine. They expanded access when demand outpaced supply, made treatment attainable for many patients, and have helped people reclaim their health. I genuinely appreciate the role compounding pharmacies have played, and I want this industry to continue to thrive.
This article is not an attack on compounding. It is a challenge—a challenge to telehealth companies, compounding pharmacies, and the industry as a whole to become the gold standard for transparency, formulation-specific validation, and patient confidence.
Patients deserve more than being told, "Don't worry...it's fine."
They deserve to understand the science behind the answer.
We May Be Asking the Wrong Question
Every summer, social media fills with photos of warm medication, melted gel packs, and packages left in the heat. The response is often immediate: "It's fine."
As I researched compounded tirzepatide stability, I noticed the same temperature excursion guidance appearing again and again across different companies and online communities, covering all pharmacies, all formulations, and all manufacturing processes.
If every pharmacy independently performed formulation-specific temperature stability studies on its own finished product and reached similar conclusions, that's wonderful.
Publish them.
Science becomes stronger when every manufacturer demonstrates the stability of the exact formulation it produces.
The Finished Product Matters
Tirzepatide is only one part of the finished medication. Different pharmacies may use different concentrations, buffers, preservatives, excipients, pH targets, manufacturing processes, filling equipment, packaging systems, and quality controls.
Those differences do not automatically mean one product is better than another.
They do mean that stability is ultimately a property of the finished formulation—not just the active ingredient.
What Eli Lilly Taught Me About Cold Chain
Perhaps the most surprising part of my research wasn't what I learned about compounding.
It was what I learned about Eli Lilly.
Lilly invented tirzepatide. No company understands this molecule better. They invested years studying its chemistry, stability, manufacturing, packaging, and distribution.
One thing became immediately obvious.
Eli Lilly takes protecting its product during shipping very seriously.
Zepbound is shipped using engineered cold-chain packaging, carefully managed logistics, and detailed storage guidance intended to protect product quality until it reaches the patient's refrigerator.
That doesn't tell us how every compounded formulation behaves.
But it does tell us something important.
The company that knows tirzepatide better than anyone believes protecting it during shipment at great financial and logistical expense deserves significant attention.
That made me stop and ask:
Why?
The Question Raised by the Pharmacy Hub Excursion Guide
As I continued researching, I noticed something else.
Whenever patients posted photos of warm compounded medication on Facebook, Reddit, and other online communities, someone would often respond by sharing the same Pharmacy Hub temperature excursion guide, which seems to match BPI Labs Tirzepatide temperature excursion data.
And, it appears this has somehow become the universal answer.
No matter which pharmacy produced the medication.
No matter what formulation was used.
The more I saw this happen, the more one question kept coming back to me.
How do we know one excursion guide applies equally to every finished formulation?
Whether someone uses data from BPI or another pharmacy isn't really the point.
The sophistication of the manufacturing systems BPI publicly describes includes commercial cGMP manufacturing, advanced aseptic processing, in-house analytical laboratories, microbiology testing, validation programs, and comprehensive quality systems.
If those high-tech 503B Pharmaceutical investments contributed to a highly stable finished formulation capable of tolerating those documented temperature excursions, then they deserve recognition for that achievement.
Perhaps it does.
But can we assume this? Should we?
If every 503A and 503B pharmacy independently performed formulation-specific stability studies on its own finished product and reached similar conclusions...
Wonderful.
I'd genuinely love to see those studies.
Because if ALL compounded formulations truly maintain their quality after temperature excursions well beyond the refrigerated conditions recommended for Zepbound, that raises an intriguing question.
Eli Lilly has invested billions of dollars developing tirzepatide. If creating a formulation that reliably maintains its quality through broader temperature excursions is truly achievable, it's reasonable to wonder why Lilly continues to invest so heavily in engineered cold-chain packaging and temperature-controlled shipping.
There may be perfectly valid scientific, regulatory, manufacturing, formulation-specific, or commercial reasons.
I don't know the answer.
But I believe it's a question worth asking.
And if compounded formulations have truly achieved that level of stability, that is an impressive accomplishment—one worthy of formulation-specific evidence and something every pharmacy should be proud to publish.
I'm not suggesting the Pharmacy Hub guidance is wrong.
I'm asking a different question:
How do we know it's the right guidance for the specific medication from a specific pharmacy sitting in that patient's refrigerator?
That isn't criticism.
That's pharmaceutical science.
A Simple Opportunity
Improving patient confidence does not require reinventing the wheel.
Publish formulation-specific stability data whenever possible.
Explain the science behind shipping recommendations.
Offer enhanced cold-chain shipping options for patients who want additional assurance.
Give patients choices.
Transparency doesn't weaken confidence.
It strengthens it.
Conclusion
Science has always advanced because people were willing to ask thoughtful questions.
Patients asking thoughtful questions about medications they inject into their own bodies should never be dismissed.
If the compounded GLP-1 industry has achieved something extraordinary, show us the science.
Transparency doesn't weaken trust.
It earns it.
Sources & Further Reading
• Eli Lilly Zepbound Prescribing Information
• LillyDirect storage and shipping information
• FDA information on compounded drugs
• USP guidance on packaging, storage, and sterile compounding
• ICH Stability Guidelines
• Publicly available Pharmacy Hub excursion guidance
I received 2 day shipping from Quaker. I live in Georgia, and it's super hot. I just received my package from Fedex.
Prior to this, I had been using Lilly Direct. The branded medications are top-notch, and the shipping, especially in the summer, is perfect. Always arrived with ice packs still frozen. They are super careful with their medication because it is so temperature-sensitive.
I have a very hard time trusting and respecting a pharmacy that does not ship overnight during the summer months.
Quaker did use their new thermos shipping, but honest to god, when I opened that package, everything, including the insides of the thermos and the little cold sticks, were HOT, not warm, HOT. HOT like it was sitting in a car where temps reach 115 degrees in this Georgia sun.
I would like to make a suggestion to GIMMECARE.
I would MUCH RATHER pay the difference between 2-day and OVERNIGHT SHIPPING during the summer months than risk that my expensive and very valuable medications can suffer damage in this summer heat! I am doubtful that this medication is even viable at this point!
IT SHOULD ALL BE OVERNIGHTED DURING THE SUMMER, ESPECIALLY DESTINATIONS IN THE SOUTHERN PART OF THE UNITED STATES. This should TRULY BE A NO-BRAINER.
I joined Gimme through Reddit, because I have Alpha Gal Syndrome and other food allergies and intolerances and after some rough experiences, found it is safest for me to use straight TIRZ with no additives.
I can no longer afford Zep, so I requested Apothecary. I have heard from the Dr that my script was approved and the script was submitted. However, it doesn't show on any of the portal messaging that the script was submitted to Apothcary. I realize Hallendale would be the only other option for straight Tirz.
Can I assume I will be receiving my medication from Apothecary because that is what I requested?